158 related articles for article (PubMed ID: 33006741)
41. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells.
Liu C; Liu XN; Wang GL; Hei Y; Meng S; Yang LF; Yuan L; Xie Y
Int J Nanomedicine; 2017; 12():2407-2425. PubMed ID: 28405164
[TBL] [Abstract][Full Text] [Related]
42. Radioiodinated agents for imaging multidrug resistant tumors.
Kortylewicz ZP; Augustine AM; Nearman J; McGarry J; Baranowska-Kortylewicz J
Med Chem; 2009 Mar; 5(2):171-81. PubMed ID: 19275716
[TBL] [Abstract][Full Text] [Related]
43. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
44. Enhanced therapeutic efficacy of LHRHa-targeted brucea javanica oil liposomes for ovarian cancer.
Ye H; Liu X; Sun J; Zhu S; Zhu Y; Chang S
BMC Cancer; 2016 Oct; 16(1):831. PubMed ID: 27793127
[TBL] [Abstract][Full Text] [Related]
45. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
46. α
Wang Z; Zhao S; Gu W; Dong Y; Meng F; Yuan J; Zhong Z
Acta Biomater; 2021 Apr; 124():348-357. PubMed ID: 33561562
[TBL] [Abstract][Full Text] [Related]
47. Preparation of novel butyryl galactose ester-modified coix component microemulsions and evaluation on hepatoma-targeting in vitro and in vivo.
Liu MJ; Qu D; Chen Y; Liu CY; Liu YP; Ding XF
Drug Deliv; 2016 Nov; 23(9):3444-3451. PubMed ID: 27198659
[TBL] [Abstract][Full Text] [Related]
48. Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo.
Kang BK; Chon SK; Kim SH; Jeong SY; Kim MS; Cho SH; Lee HB; Khang G
Int J Pharm; 2004 Nov; 286(1-2):147-56. PubMed ID: 15501011
[TBL] [Abstract][Full Text] [Related]
49. A microemulsion co-loaded with Schizandrin A-docetaxel enhances esophageal carcinoma treatment through overcoming multidrug resistance.
Su X; Gao C; Shi F; Feng X; Liu L; Qu D; Wang C
Drug Deliv; 2017 Nov; 24(1):10-19. PubMed ID: 28155336
[TBL] [Abstract][Full Text] [Related]
50. The effect of dual ligand-targeted micelles on the delivery and efficacy of poorly soluble drug for cancer therapy.
Sawant RR; Jhaveri AM; Koshkaryev A; Qureshi F; Torchilin VP
J Drug Target; 2013 Aug; 21(7):630-8. PubMed ID: 23594094
[TBL] [Abstract][Full Text] [Related]
51. A myristoylated cell-penetrating peptide bearing a transferrin receptor-targeting sequence for neuro-targeted siRNA delivery.
Youn P; Chen Y; Furgeson DY
Mol Pharm; 2014 Feb; 11(2):486-95. PubMed ID: 24387132
[TBL] [Abstract][Full Text] [Related]
52. Simultaneous delivery of chemotherapeutic and thermal-optical agents to cancer cells by a polymeric (PLGA) nanocarrier: an in vitro study.
Tang Y; Lei T; Manchanda R; Nagesetti A; Fernandez-Fernandez A; Srinivasan S; McGoron AJ
Pharm Res; 2010 Oct; 27(10):2242-53. PubMed ID: 20694526
[TBL] [Abstract][Full Text] [Related]
53. Characterization of 9-nitrocamptothecin-in-cyclodextrin-in-liposomes modified with transferrin for the treating of tumor.
Chen J; Lu S; Gu W; Peng P; Dong J; Xu F; Yang X; Xiong Z; Yang X
Int J Pharm; 2015 Jul; 490(1-2):219-28. PubMed ID: 26004006
[TBL] [Abstract][Full Text] [Related]
54. Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy.
Amreddy N; Muralidharan R; Babu A; Mehta M; Johnson EV; Zhao YD; Munshi A; Ramesh R
Int J Nanomedicine; 2015; 10():6773-88. PubMed ID: 26604751
[TBL] [Abstract][Full Text] [Related]
55. Formulation, preparation and evaluation of an intravenous emulsion containing Brucea javanica oil and Coix Seed oil for anti-tumor application.
Yu YL; Lu Y; Tang X; Cui FD
Biol Pharm Bull; 2008 Apr; 31(4):673-80. PubMed ID: 18379061
[TBL] [Abstract][Full Text] [Related]
56. Docosahexaenoic acid-mediated, targeted and sustained brain delivery of curcumin microemulsion.
Shinde RL; Devarajan PV
Drug Deliv; 2017 Nov; 24(1):152-161. PubMed ID: 28156175
[TBL] [Abstract][Full Text] [Related]
57. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
Nag M; Gajbhiye V; Kesharwani P; Jain NK
Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
[TBL] [Abstract][Full Text] [Related]
58. Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model.
Pattni BS; Nagelli SG; Aryasomayajula B; Deshpande PP; Kulkarni A; Hartner WC; Thakur G; Degterev A; Torchilin VP
Pharm Res; 2016 Oct; 33(10):2540-51. PubMed ID: 27351426
[TBL] [Abstract][Full Text] [Related]
59. Sterically Bulky Caging of Transferrin for Photoactivatable Intracellular Delivery.
Yamaguchi S; Takamori S; Yamamoto K; Ishiwatari A; Minamihata K; Yamada E; Okamoto A; Nagamune T
Bioconjug Chem; 2021 Aug; 32(8):1535-1540. PubMed ID: 34328322
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
